Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Evaluation of COPD Specific Quality of Life Assessment Questionnaires (the COPD Assessment Test, the Clinical COPD Questionnaire, the COPD Severity Score and the Airways Questionnaire 20 as Predictive Tools for Risk of Acute COPD Exacerbations

NCT01248507 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01248507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01248507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Evaluation of COPD Specific Quality of Life Assessment Questionnaires (the COPD Assessment Test, the Clinical COPD Questionnaire, the COPD Severity Score and the Airways Questionnaire 20 as Predictive Tools for Risk of Acute COPD Exacerbations
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
April 30, 2013
Enrollment
634 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd